Current problems in hypertension and nephrology
作者： Maciej Banach , Jacek Rysz
DOI: 10.1517/14656566.2010.522569
关键词: Dyslipidemia 、 Pharmacotherapy 、 Medicine 、 Internal medicine 、 Blood pressure 、 Nephrology 、 Hypertensive Nephropathy 、 Kidney disease 、 Hypotensive Drugs 、 Intensive care medicine 、 Angiotensin Receptor Blockers
摘要: The aim of this issue Expert Opinion on Pharmacotherapy is to present the most important and controversial problems in hypertension nephrology. To end, points current (2009) recommendations European Society Hypertension (ESH) are discussed, including aspects related treatment – role beta-blockers, combined therapy with angiotensin-converting enzyme inhibitors (ACEIs) angiotensin receptor blockers (ARBs) elderly patients, destiffening therapy. authors also for management dyslipidemia hypertensive chronic kidney disease (CKD) new strategies prevent cardiovascular risk CKD optimal level blood pressure patients nephropathy which hypotensive drugs nephroprotective. Editors aware that many other have not been addressed t...
informahealthcare.com参考文章(32)
Kamal Heydari, Mohammad A. Ramezani, Maasoomeh Dastanpour, Reza Fadaee-Nobari, Seyed R. Eshaghi, Determinants of awareness, treatment and control of hypertension in Isfahan, Central Iran. Archives of Medical Science. ,vol. 5, pp. 523- 530 ,(2009)
Aleksander Goch, Maciej Banach, Dimitri P. Mikhailidis, Jacek Rysz, Jan Henryk Goch, Endothelial Dysfunction in Patients with Noncomplicated and Complicated Hypertension Clinical and Experimental Hypertension. ,vol. 31, pp. 20- 30 ,(2009) , 10.1080/10641960802409846
Wilbert S Aronow, Current role of beta-blockers in the treatment of hypertension Expert Opinion on Pharmacotherapy. ,vol. 11, pp. 2599- 2607 ,(2010) , 10.1517/14656566.2010.482561
Agata Bielecka-Dabrowa, Wilbert S. Aronow, Jacek Rysz, Maciej Banach, Current Place of Beta-Blockers in the Treatment of Hypertension Current Vascular Pharmacology. ,vol. 8, pp. 733- 741 ,(2010) , 10.2174/157016110793563861
Alberto Zanchetti, Ettore Ambrosioni, Enrico Agabiti-Rosei, Krzysztof Narkiewicz, Robert Fagard, Renata Cifkova, Margus Viigimaa, Serap Erdine, Pieter A. Van Zwieten, Mark J. Caulfield, Antony Heagerty, Anna Dominiczak, Harry A.J. Struijker-Boudier, Luis Ruilope, Stéphane Laurent, Josep Redon, Denis Clément, Antonio Coca, Michael H. Olsen, Michel Burnier, Hermann Haller, Guido Grassi, Giuseppe Mancia, Csaba Farsang, Sverre E. Kjeldsen, Roland E. Schmieder, Peter Nilsson, Karl Heinz Rahn, Jean Michel Mallion, Wolfgang Kiowski, Athanasios Manolis, José Rodicio, Reappraisal of European guidelines on hypertension management:: A European Society of Hypertension Task Force document ,(2011)
Ravi V. Desai, Maciej Banach, Mustafa I. Ahmed, Marjan Mujib, Inmaculada Aban, Thomas E. Love, Michel White, Gregg Fonarow, Prakash Deedwania, Wilbert S. Aronow, Ali Ahmed, Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). American Journal of Cardiology. ,vol. 106, pp. 221- 227 ,(2010) , 10.1016/J.AMJCARD.2010.02.032
Satoshi Jissho, Kenei Shimada, Haruyuki Taguchi, Ken Yoshida, Shota Fukuda, Hidemasa Tanaka, Junichi Yoshikawa, Minoru Yoshiyama, Masao Ishii, Yoshio Goto, Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients. - The Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) -. Japanese Circulation Journal-english Edition. ,vol. 74, pp. 938- 945 ,(2010) , 10.1253/CIRCJ.CJ-09-0722
Finn Gustafsson, Julian Segura, Luis M Ruilope, How should we manage heart failure developing in patients already treated with angiotensin-converting enzyme inhibitors and beta-blockers for hypertension, diabetes or coronary disease? Journal of Hypertension. ,vol. 28, pp. 1595- 1598 ,(2010) , 10.1097/HJH.0B013E32833984B8
Luis M Ruilope, Julian Segura, ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations. Expert Opinion on Pharmacotherapy. ,vol. 11, pp. 2619- 2623 ,(2010) , 10.1517/14656566.2010.522992
Piero Ruggenenti, Paolo Cravedi, Giuseppe Remuzzi, Increased angiotensin-receptor blocking is not the first option Nature Reviews Nephrology. ,vol. 5, pp. 367- 368 ,(2009) , 10.1038/NRNEPH.2009.77